Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).

Advances in Experimental Medicine and Biology

Volumn 632, Issue , 2008, Pages 61-69

  Leung, Lawrence L K ^a   Nishimura, Toshihiko ^a   Myles, Timothy ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; BRADYKININ; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; OSTEOPONTIN; PROTEIN C; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; CARBOXYPEPTIDASE B; THROMBIN; THROMBOMODULIN;

ABDOMINAL AORTA ANEURYSM; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; BLOOD CLOT LYSIS; CATALYSIS; DISEASE PREDISPOSITION; FEEDBACK SYSTEM; HYPOTENSION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LUNG; LUNG ALVEOLITIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REVIEW; TISSUE; WILD TYPE; ANIMAL; BIOLOGICAL MODEL; BLOOD; CHEMISTRY; METABOLISM; MOUSE; PHYSIOLOGY;

MUS;

ANIMALS; CARBOXYPEPTIDASE B; CARBOXYPEPTIDASE U; INFLAMMATION; MICE; MODELS, IMMUNOLOGICAL; THROMBIN; THROMBOMODULIN;

EID: 58149328581     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78952-1_5     Document Type: Review

References (15)

1. Bajzar, L., Morser, J., Nesheim, M. (1996). TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 271, 16603-16608
2. Bernard, G.R., Vincent, J.L., Laterre, P.F., LaRosa, S.P., et al. (2001). Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med344, 699-709
3. Broze, G., Higuchi, D.A. (1996). Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. Blood 88, 3815-3823
4. Campbell, W.D., Lazoura, E., Okada, N., Okada, H. (2002). Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol Immunol 46, 131-134
5. Coughlin, S.R. (2005). Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3, 1800-1814
6. Esmon, C.T. (2003). The protein C pathway. Chest 124, 26S-32S
7. Esmon, C.T. (2005). The interactions between inflammation and coagulation. Br J Haematol 131, 417-430
8. Gibbs, C.S., Coutre, S.E., Tsiang, M., Li, W.X., Jain, A.K., Dunn, K.E., Law, V.S., Mao, C.T., Matsumura, S.Y., Mejsa, S.J., Paborsky, L.R., Leung, L.L.K. (1995). Conversion of thrombin into an anticoagulant by protein engineering. Nature 378, 413-416
9. Leung, L.L.K., Gibbs, C.S. (1997). Modulation of thrombin's procoagulant and anticoagulant properties. Thromb Haemost 78, 577-580
10. Myles, T., Nishimura, T., Yun, T.H., Nagashima, M., Morser, J., Patterson, A.J., Pearl, R.G., Leung, L.L.K. (2003). Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. J Biol Chem 278, 51059-51067
11. Nishimura, T., Myles, T., Piloponsky, P., Kao, P., Berry, G.J., Leung, L.L.K. (2007). Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo. Blood 109, 1992-1997
12. Redlitz, A., Tan, A.K., Eaton, D.L., Plow, E.F. (1995). Plasma carboxypeptidases as regulators of the plasminogen system. J Clin Invest 96, 2534-2538
13. Shinohara, T., Sakurada, C., Suzuki, T., Takeuchi, O., Campbell, W., Ikeda, S., Okada, N., Okasda, H. (1994). Pro-carboxypeptidase R cleaves bradykinin following activation. Int Arch Allergy Immunol 103, 400-404
14. Song, J., Nishimura, T., Garcia, M., Myles, T., Ho, P., Du, X.Y., Sharif, S., Leung, L., Robinson, W. (2007). Thrombin-activatable carboxypeptidase B prevents anti-collagen antibody induced arthritis. Clinical Immunology 123 Suppl, S98
15. Tsiang, M., Paborsky, L.R., Li, W.X., Jain, A.K., Mao, C.T., Dunn, K.E., Lee, D.W., Matsumura, S.Y., Matteucci, M.D., Coutre, S.E., Leung, L.L.K., and Gibbs, C.S. (1996). Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo. Biochemistry 35, 16449-16457